Related Experiment Video
Updated: May 4, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2
Kristina Heyne1, Juliane Förster, Roland Schüle
1José Carreras Research Center and Internal Medicine I, University of Saarland Medical Center, 66421 Homburg/Saar, Germany and Department of Urology, Center for Clinical Research, University of Freiburg, 79106 Freiburg, Germany.
Abstract:
NIR (novel INHAT repressor) can bind to p53 at promoters and inhibit p53-mediated gene transactivation by blocking histone acetylation carried out by p300/CBP. Like NIR, the E3 ubiquitin ligase MDM2 can also bind and inhibit p53 at promoters. Here, we present data indicating that NIR, which shuttles between the nucleolus and nucleoplasm, not only binds to p53 but also directly to MDM2, in part via the central acidic and zinc finger domain of MDM2 that is also contacted by several other nucleolus-based MDM2/p53-regulating proteins. Like some of these, NIR was able to inhibit the ubiquitination of MDM2 and stabilize MDM2; however, unlike these nucleolus-based MDM2 regulators, NIR did not inhibit MDM2 to activate p53. Rather, NIR cooperated with MDM2 to repress p53-induced transactivation. This cooperative repression may at least in part involve p300/CBP. We show that NIR can block the acetylation of p53 and MDM2. Non-acetylated p53 has been documented previously to more readily associate with inhibitory MDM2. NIR may thus help to sustain the inhibitory p53:MDM2 complex, and we present evidence suggesting that all three proteins can indeed form a ternary complex. In sum, our findings suggest that NIR can support MDM2 to suppress p53 as a transcriptional activator.
Insights
Novel INHAT repressor (NIR) binds p53 and MDM2, cooperating with MDM2 to suppress p53 transcriptional activity by inhibiting acetylation and stabilizing the p53:MDM2 complex.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- p53 is a tumor suppressor regulated by MDM2.
- MDM2 inhibits p53 activity through ubiquitination and promoter binding.
- Histone acetylation by p300/CBP is crucial for p53-mediated gene transactivation.
Purpose of the Study:
- Investigate the interaction of NIR with p53 and MDM2.
- Elucidate NIR's role in regulating p53 activity.
- Determine the mechanism by which NIR influences the p53-MDM2 complex.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions.
- Western blotting to assess protein levels and acetylation status.
- Reporter assays to measure p53-mediated transactivation.
Main Results:
- NIR binds directly to both p53 and MDM2.
- NIR inhibits MDM2 ubiquitination and stabilizes MDM2.
- NIR cooperates with MDM2 to repress p53 transactivation by blocking p53 and MDM2 acetylation.
- NIR promotes the formation of a ternary complex involving p53, MDM2, and NIR.
Conclusions:
- NIR acts as a co-repressor with MDM2 to suppress p53 transcriptional activity.
- NIR's mechanism involves stabilizing the inhibitory p53:MDM2 complex through acetylation inhibition.
- NIR represents a potential therapeutic target in cancers where p53 is functional.
Related Concept Videos
Abnormal Proliferation
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Regulation of the Unfolded Protein Response
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Co-activators and Co-repressors

